MONTRÉAL, March 7, 2016 /CNW Telbec/ – Green Cross Biotherapeutics (GCBT), a Montréal-based biopharmaceutical company and member of the Green Cross family, is pleased to announce that Health Canada has approved its application to proceed with a multi-centre Phase III clinical…